Where I see patients (3)
Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment.
The Journal of infectious diseases
Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
The human microbiome and gut-liver axis in people living with HIV.
Current HIV/AIDS reports
Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B...
Nonalcoholic Fatty Liver Disease in HIV Database
Vibration-controlled transient elastography (VCTE) measures the speed of a mechanically generated shear wave across the liver to derive a liver stiffness measurement (LSM), which corresponds to the liver fibrosis stage. LSM is mea...
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
Prevalence of hepatic steatosis in PLWH will be reported as the number of participants with hepatic steatosis, defined by controlled attenuation parameter (CAP) ≥263 dB/m, over the total number of participants assessed.
Rapid HCV Treatment Access for Persons Who Use Drugs
Proportion of participants who start HCV treatment in each arm.
HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
Time (in days) to first of any of the following events: death or graft failure or SAE or HIV breakthrough or opportunistic infection